Metcalfe, Amy L

7 enregistrements totalisant 3,311,001.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.

Intégrer ce graphique

Par ministère

Enregistrements

Metcalfe, Amy L $2,400,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2021-2022
Canada

The specific objective(s) of this funding opportunity are to: • Support the development of structured, openly accessible and sustainable training and mentoring platforms that build capacity in areas...

Metcalfe, Amy L $306,001.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2018-2019
Canada

Impact of Maternal Cancer and In-Utero Exposure to Chemotherapy on Long-Term Child Health

Metcalfe, Amy L $150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2021-2022
Canada

The specific objective of this funding opportunity is to: Improve our understanding of, response to, and recovery from co-occurring stressful and traumatic events that stem from the current COVID-1...

Metcalfe, Amy L $150,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
Research in Priority Areas
EF 2021-2022
Canada

This is a directed grant funding opportunity to the Health Research Training Platform (HRTP) Pilot grantees, for funding for patient engagement enhancement activities to be funded through the SPOR rin...

METCALFE, Amy L $135,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2012-2013
Canada

Best Clinical Practices Research for Cardiovascular Disease in Pregnancy

Metcalfe, Amy L $125,000.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2016-2017
Canada

Optimizing the Management of Chronic Disease during Pregnancy

Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
EF 2017-2018
Canada

Survival, recurrence and subsequent obstetrical outcomes following pregnancy-associated and postpartum cancer